Dynamics in the Prostate Immune Microenvironment Induced by Androgen Deprivation Therapy
The Prostate · 2025
DOI: 10.1002/pros.24828 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Prostate, 2025. Verfasst von Yoshinori Yanai und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Keio University School of Medicine, Tokyo, Japan. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Androgen Antagonists, Tumor Microenvironment, Prostate. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: This work was supported in part by a Grant-in-Aid for Scientific Research (#20H03817 to T.K.) from the Ministry of Education, Culture, Sports, Science and Tech….
Abstract (Originalsprache)
Background
The influence of testosterone on the prostate's immune microenvironment remains unclear. This study aims to elucidate the dynamics of immune cells in the prostate following androgen deprivation therapy (ADT).
Methods
We retrospectively compared prostate needle biopsy and radical prostatectomy specimens from 33 patients who underwent both procedures, along with neoadjuvant ADT at a single institution. Immune cell infiltration in the cancer and stroma areas was assessed using multiplex fluorescence immunohistochemistry.
Results
Post‐ADT, all immune cells, including CD4 + T cells, CD8 + T cells, Foxp3 + regulatory T cells, CD204 + macrophages, and CD20 + B cells, significantly increased in the prostatectomy specimen. However, few immune cells were detected in the biopsy of the same patients ( p < 0.001). The number of CD20 + B cells in the cancer area was significantly lower post‐ADT in high‐risk cases according to the NCCN classification ( p = 0.020). This difference was significantly associated with the Gleason Grade Group, rather than PSA levels or T classification ( p < 0.001). However, no significant difference was observed in the recurrence rate between Grade Groups 1, 2, 3 and 4, 5 ( p = 0.991). There was no significant difference in immune cells other than CD20 + B cells when divided into NCCN classifications.
Conclusions
The marked increase in immune cells following ADT suggests an intensified immune response against prostate cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, Keio University School of Medicine, Tokyo, Japan.
- Division of Clinical Chemotherapy, The Cancer Chemotherapy Center of Japanese Foundation for Cancer Research, Tokyo, Japan.
- Department of Diagnostic Pathology, National Hospital Organization Saitama Hospital, Saitama, Japan.
- Department of Diagnostic Pathology, Keio University School of Medicine, Tokyo, Japan.
- Department of Advanced Medical Development, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.
ORCID-Profile: Takeo Kosaka, Kazuhiro Matsumoto
Förderung
- This work was supported in part by a Grant-in-Aid for Scientific Research (#20H03817 to T.K.) from the Ministry of Education, Culture, Sports, Science and Tech…
Zitieren
APA
Yanai, Y., Kosaka, T., Mikami, S., Arai, M., Watanabe, K., Takeda, T., Matsumoto, K., Yamashita, M., Kitano, S., & Oya, M. (2025). Dynamics in the Prostate Immune Microenvironment Induced by Androgen Deprivation Therapy. The Prostate. https://doi.org/10.1002/pros.24828
Vancouver
Yanai Y, Kosaka T, Mikami S, Arai M, Watanabe K, Takeda T, et al. Dynamics in the Prostate Immune Microenvironment Induced by Androgen Deprivation Therapy. The Prostate. 2025. doi:10.1002/pros.24828
BibTeX
@article{Yanai2025,
author = {Yanai, Yoshinori and Kosaka, Takeo and Mikami, Shuji and Arai, Masashi and Watanabe, Keitaro and Takeda, Toshikazu and Matsumoto, Kazuhiro and Yamashita, Makiko and Kitano, Shigehisa and Oya, Mototsugu},
title = {Dynamics in the Prostate Immune Microenvironment Induced by Androgen Deprivation Therapy},
journal = {The Prostate},
year = {2025},
doi = {10.1002/pros.24828}
}
EUVIMED